These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 19035013)
1. On call. I don't understand the problem with Vytorin. The two components when used separately work fine, but when mixed together things change. Why? Simon HB Harv Mens Health Watch; 2008 Oct; 13(3):8. PubMed ID: 19035013 [No Abstract] [Full Text] [Related]
2. Ezetimibe/Simvastatin (vytorin) for hypercholesterolemia. Goldman-Levine JD; Bohlman LG Am Fam Physician; 2005 Nov; 72(10):2081-2. PubMed ID: 16342840 [No Abstract] [Full Text] [Related]
3. Vytorin: a combination of ezetimibe and simvastatin. Med Lett Drugs Ther; 2004 Sep; 46(1191):73-4. PubMed ID: 15365507 [No Abstract] [Full Text] [Related]
8. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis (the SEAS trial). Farmer JA Curr Atheroscler Rep; 2009 Mar; 11(2):82-3. PubMed ID: 19228479 [No Abstract] [Full Text] [Related]
9. A case study of single-pill combination therapy: the ezetimibe/simvastatin combination for treatment of hyperlipidemia. Huang X; Chen DY ChemMedChem; 2012 Nov; 7(11):1882-94. PubMed ID: 22907901 [TBL] [Abstract][Full Text] [Related]
10. Ezetimibe revisited. Med Lett Drugs Ther; 2008 Aug; 50(1293):67-8. PubMed ID: 18719525 [No Abstract] [Full Text] [Related]
11. Is it over for ezetimibe? Robinson JG; Davidson M Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):781-3. PubMed ID: 18570614 [No Abstract] [Full Text] [Related]
12. The development of novel anti-hyperlipidemic drugs: a tough business gets tougher. Krause BR Curr Opin Investig Drugs; 2008 Sep; 9(9):945-9. PubMed ID: 18729000 [No Abstract] [Full Text] [Related]
13. Three new drugs for hyperlipidemia. Conn Med; 2003 May; 67(5):279-81. PubMed ID: 12802842 [No Abstract] [Full Text] [Related]
14. Niaspan: new hope for heart patients. Creavin T Drug Discov Today; 2005 Jan; 10(1):4-5. PubMed ID: 15676289 [No Abstract] [Full Text] [Related]
15. Three new drugs for hyperlipidemia. Med Lett Drugs Ther; 2003 Mar; 45(1151):17-9. PubMed ID: 12612501 [No Abstract] [Full Text] [Related]
16. Controversies surround heart drug study: questions about Vytorin and trial sponsors' conduct. Mitka M JAMA; 2008 Feb; 299(8):885-7. PubMed ID: 18314425 [No Abstract] [Full Text] [Related]
17. Utility of ezetimibe. Ashikaga H; Blumenthal RS; Jones SR Am J Cardiol; 2009 May; 103(9):1321-2. PubMed ID: 19406279 [No Abstract] [Full Text] [Related]
18. FPIN's clinical inquiries. Best alternatives to statins for treating hyperlipidemia. Bouknight P; Mackler L; Heffington M Am Fam Physician; 2007 Oct; 76(7):1027-9. PubMed ID: 17956075 [No Abstract] [Full Text] [Related]
19. The SHARP trial: lessons learnt; answers and more questions! Turagam M; Velagapudi P Int J Cardiol; 2012 Apr; 156(1):e6. PubMed ID: 21849215 [No Abstract] [Full Text] [Related]